SKI Market

A+| A| A-|

Indian Indices

Sensex

77,844.52 -114.00
( -0.15%)

Global Indices

Nasdaq

49,628.48 -303.12
(-0.61%)

Dow Jones

7,359.75 -26.37
(-0.36%)

Hang Seng

62,916.52 3,403.40
(5.72%)

Nikkei 225

10,288.99 -149.67
(-1.43%)

Forex

USD-INR

95.18 0.09
(0.09%)

EUR-INR

111.29 -0.04
(-0.04%)

GBP-INR

128.89 -0.01
(-0.01%)

JPY-INR

0.60 0.00
(-0.23%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

411.5542386

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

24.03

110088.66

EPS(TTM)

Face Value()

Div & Yield %

56.72

1.17

Back

mrf ltd

Swan Corp reports consolidated net loss of Rs 3.82 crore in the September 2025 quarter

Nov 16,2025

Net loss of Swan Corp reported to Rs 3.82 crore in the quarter ended September 2025 as against net profit of Rs 51.28 crore during the previous quarter ended September 2024. Sales rose 10.28% to Rs 1138.34 crore in the quarter ended September 2025 as against Rs 1032.19 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	1138.34	1032.19	10
OPM %	0.44	11.64	-
PBDT	31.04	85.76	-64
PBT	0.61	57.40	-99
NP	-3.82	51.28	PL

77,844.52 -114.00 ( -0.15%)

49,628.48 -303.12 (-0.61%)

7,359.75 -26.37 (-0.36%)

62,916.52 3,403.40 (5.72%)

10,288.99 -149.67 (-1.43%)

95.18 0.09 (0.09%)

111.29 -0.04 (-0.04%)

128.89 -0.01 (-0.01%)

0.60 0.00 (-0.23%)